1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
ADAMA Ltd. Class A

ADAMA Ltd. Class A

2.68
HKD
-0.01
(-0.37%)
14.69BMarket Cap
Oct 30Next Earn
ADAMA Ltd. Class A
SZSE:200553
(Shenzhen Stock Exchange)

Recent

price

2.68

P/E

ratio

- -

div

yld

10.76%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.21
1.46
1.8
2.37
2.41
1.67
6.01
4.65
5.01
5
5.53
6.31
7.29
6.43
5.8
5.69
- -
Revenue per Share
0.02
0.04
0.08
0.25
0.38
0.11
0.1
0.3
0.46
0.05
0.07
0.03
0.12
-0.32
-0.57
-0.21
- -
Basic EPS, GAAP
-0.18
-0.01
0.06
0.34
0.23
-0.02
0.78
0.48
-0.2
-0.17
0.01
0.4
-0.34
0.05
0.46
0.56
- -
Free Cash Flow per Basic Share
0.04
0.05
0.05
0.07
0.05
0.07
0.19
0.14
0.13
0.17
0.13
0.15
0.17
0.24
0.21
0.18
0.25
Dividend per Share
0.87
0.89
0.97
1.19
1.54
1.61
13.01
3.68
4.25
4.18
4.16
4.13
4.53
4.3
3.72
3.45
3.46
Book Value per Share
0.76
0.78
0.85
1.08
1.44
1.49
6
2.13
2.41
2.25
2.25
2.22
2.54
2.28
1.79
1.63
1.73
Tangible Book Value per Share
1,300
1,300
1,300
1,300
1,300
1,300
3,673
5,128
5,359
5,514
5,148
4,922
5,131
5,095
5,085
5,087
3,024
Basic Weighted Avg Shares
1,570
1,901
2,345
3,078
3,131
2,170
22,070
23,820
26,867
27,563
28,445
31,039
37,382
32,779
29,488
28,945
- -
Sales/Revenue/Turnover
6.5
6.71
9.55
16.61
22.65
10.32
8.88
11.16
9.57
6.99
6.39
6.15
7.77
2.86
2.16
5.65
- -
Operating Margin (%)
101
104
145
166
179
215
1,724
1,668
2,052
2,336
2,257
1,943
2,137
2,088
2,166
2,104
- -
Depreciation Expense
24
53
104
321
492
142
369
1,546
2,448
277
353
157
609
-1,606
-2,903
-1,046
- -
Net Income, GAAP
26.17
29.91
26.8
26.33
26.53
24.9
9.17
7.32
25.8
38.65
38.67
69.97
19.48
- -
- -
- -
- -
Effective Tax Rate (%)
1.51
2.78
4.42
10.42
15.71
6.54
1.67
6.49
9.11
1.01
1.24
0.51
1.63
-4.9
-9.85
-3.61
- -
Profit Margin (%)
166
99
-241
127
520
445
9,141
12,080
12,984
13,197
14,308
14,001
12,426
10,728
7,904
3,175
3,881
Working Capital
460
508
80
296
432
344
8,420
8,292
8,276
9,299
10,845
11,658
11,447
10,301
9,097
7,153
6,943
LT Debt
1,147
1,165
1,265
1,546
2,007
2,097
16,918
18,868
22,745
22,372
21,434
21,075
23,125
21,924
18,991
17,575
17,636
Total Equity
1.21
2.66
5.25
14.89
20.07
5.21
5.08
5.46
7.86
0.96
0.95
0.44
1.55
- -
- -
- -
- -
Return on Invested Capital (%)
2.84
3.97
6.98
16.45
21.35
6.39
0.03
7.64
9.23
2.11
2.29
1.04
3.37
- -
- -
- -
- -
Return on Capital (%)
2.13
4.62
8.6
22.9
27.68
6.91
3.88
8.64
11.76
1.23
1.61
0.74
2.76
-7.13
-14.19
-5.72
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
10,499
11,040
9,558
LT Borrowings
6,402
6,233
6,291
LT Finance Leases
751
647
653
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5,100
5,100
5,100
Market Capitalization
11,091
12,118
12,709

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
25,561
26,421
24,585
Cash, Cash Equivalents & STI
3,452
3,239
2,909
Accounts Receivable, Net
7,125
7,670
7,781
Inventories
11,608
11,672
11,281
Total Current Liabilities
22,386
22,944
20,704
Payables & Accruals
- -
- -
- -
ST Debt
10,499
11,040
9,558
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
71.49%
-3.59%
-7.45%
Free Cash Flow
-844.88%
833.48%
21.3%
Net Income, GAAP
36.11%
-22.98%
-63.98%
Sales/Revenue/Turnover
94.9%
1.07%
-1.84%
Total Cash Common Dividend
65.51%
7.58%
-12.46%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,509
7,401
6,613
7,965
29,488
2025
7,173
7,851
- -
7,266
28,945
2026
7,206
7,271
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
-0.29
-0.4
-0.46
-0.57
2025
0.03
-0.1
- -
-0.27
-0.21
2026
0.11
-0.06
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.16
0.07
0.15
0.21
2025
0.03
0.13
- -
0.13
0.18
2026
0.03
0.14
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
ADAMA Ltd. (000553.SZ) develops, manufactures, and commercializes off-patent crop protection products worldwide; its core offerings include herbicides, fungicides, and insecticides to combat weeds, diseases, and insects in agricultural crops, as well as miticides, nematicides, seed treatments, and plant growth regulators; the company also provides intermediates for active ingredients, food additives, synthetic aromatics, dietary supplements, food colors, texture and flavor enhancers, fragrance products for perfumes, cosmetics, and detergents, plus biologicals and agricultural technologies. Founded in 1945 and headquartered in Airport City, Israel, ADAMA operates as a subsidiary of Syngenta Group Co., Ltd. with manufacturing and R&D facilities primarily in Israel and China, serving farmers in over 100 countries across Europe, North America, Latin America, Asia-Pacific (including China), Africa, and the Middle East through the Crop Protection and Intermediates & Ingredients segments. In early 2024, ADAMA launched its "Fight Forward" strategic transformation plan focused on cost reduction, portfolio optimization, commercial and manufacturing excellence, and improved profitability, yielding higher adjusted gross profit, EBITDA margins, sales volumes in the second half of 2024, operating cash flow of $528 million, and free cash flow inflow of $217 million for the full year; the company registered and introduced multiple differentiated products during 2024, including new prothioconazole-based cereal fungicides such as Soratel, Forapro, Maganic, Maxentis powered by proprietary Asorbital formulation technology, dual-mode herbicides like Outshine All In, Forcefighter All In, and triple-mode Chrome, plus unique PPO herbicide Sonavio and Metamitron-based Goltix 700 SC for sugar beets; in 2025, ADAMA advanced its novel fungicide active ingredient Gilboa (flumetylsulforim), classified by FRAC as a new Group 32 mode of action targeting nucleic acid metabolism in cereals and oilseed rape for septoria, ramularia, and sclerotinia control, with approvals expected in Great Britain by 2027 and the EU by 2029; earlier moves include the 2023 completion of the AgriNova New Zealand (Grochem) acquisition to expand in biologicals, plant nutrition, and growth regulators, and prior stakes in Chinese and Paraguayan entities.